PeerVoice Clinical Pharmacology Audio

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

http://www.peervoice.com

Eine durchschnittliche Folge dieses Podcasts dauert 18m. Bisher sind 367 Folge(n) erschienen. Alle 4 Tage erscheint eine Folge dieses Podcasts
subscribe
share





Modern Management of Chronic Kidney Disease: A Look to the Future


Modern Management of Chronic Kidney Disease: A Look to the Future


share







   15m
 
 

Practice Challenges in Advanced EGFR-Mutant NSCLC: Clarifying First-Line Strategies


Practice Challenges in Advanced EGFR-Mutant NSCLC: Clarifying First-Line Strategies


share







   25m
 
 

Breaking the Cycle of Severe Hypoglycemia in Diabetes: Educating Clinicians and Patients Alike


Breaking the Cycle of Severe Hypoglycemia in Diabetes: Educating Clinicians and Patients Alike


share







   20m
 
 

Transforming Management of Early-Stage EGFR-Mutant NSCLC: Insights From the Latest Data


Transforming Management of Early-Stage EGFR-Mutant NSCLC: Insights From the Latest Data


share







   18m
 
 

Extending Overall Survival in Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC) While Maintaining Quality of Life: Can We Have it All?


Extending Overall Survival in Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC) While Maintaining Quality of Life: Can We Have it All?


share







   1h29m
 
 

Practical Approaches to Optimise Management of Advanced Renal Cell Carcinoma


Practical Approaches to Optimise Management of Advanced Renal Cell Carcinoma


share







   21m
 
 

Defining Control in Moderate-to-Severe Asthma: Where Are We Now and What Can We Do?


Defining Control in Moderate-to-Severe Asthma: Where Are We Now and What Can We Do?


share







   18m
 
 

Unmet Needs in Familial Mediterranean Fever (FMF): Real-Life Data, the Patient Perspective, and the Role of Anti–IL-1 Therapy


Unmet Needs in Familial Mediterranean Fever (FMF): Real-Life Data, the Patient Perspective, and the Role of Anti–IL-1 Therapy


share







   59m
 
 

Best Practices for MET Mutation Testing in NSCLC: The Role of the Oncologist and the Pathologist


Best Practices for MET Mutation Testing in NSCLC: The Role of the Oncologist and the Pathologist


share







   16m
 
 

Novel Therapies for Patients With DLBCL: What Does the Future Hold?


Novel Therapies for Patients With DLBCL: What Does the Future Hold?


share







 2020-10-23  1h4m